Aberrant local renin-angiotensin II responses in the pathogenesis of primary sclerosing cholangitis

Medical Hypotheses

Volumn 61, Issue 1, 2003, Pages 64-67

  Patel, Tushar ^a  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE DUCT OBSTRUCTION; BILIARY CIRRHOSIS; CARCINOGENESIS; CELL STRUCTURE; CHOLESTASIS; CHRONIC DISEASE; HISTOPATHOLOGY; HORMONE SYNTHESIS; IDIOPATHIC DISEASE; INFLAMMATION; ISCHEMIA; PATHOGENESIS; PORTAL VEIN; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0038677991     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(03)00106-3     Document Type: Review

References (21)

1. Angulo P., Lindor K. D. Primary biliary cirrhosis and primary sclerosing cholangitis. Clin Liver Dis 1999; 3: 529-570.
2. Farrant J. M. Definition of primary sclerosing cholangitis. J Hepatobiliary Pancreat Surg 1999; 6: 329-332.
3. Ludwig J. Surgical pathology of the syndrome of primary sclerosing cholangitis. Am J Surg Pathol 1989; 13: 43-49.
4. Narayanan Menon K. V., Wiesner R. H. Etiology and natural history of primary sclerosing cholangitis. J Hepatobiliary Pancreat Surg 1999; 6: 343-351.
5. Cullen S., Chapman R. Aetiopathogenesis of primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 2001; 15: 577-589.
6. Donaldson P. T., Norris S. Immunogenetics in PSC. Best Pract Res Clin Gastroenterol 2001; 15: 611-627.
7. Terblanche J., Allison H. F., Northover J. M. An ischemic basis for biliary strictures. Surgery 1983; 94: 52-57.
8. Sanchez-Urdazpal L., Gores G. J., Ward E. M., Maus T. P., Wahlstrom H. E., Moore S. B. et al. Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology 1992; 16: 49-53.
9. Zajko A. B., Campbell W. L., Logsdon G. A., Bron K. M., Tzakis A., Esquivel C. O. et al. Cholangiographic findings in hepatic artery occlusion after liver transplantation. AJR Am J Roentgenol 1987; 149: 485-489.
10. Ludwig J., Batts K. P., MacCarty R. L. Ischemic cholangitis in hepatic allografts. Mayo Clin Proc 1992; 67: 519-526.
11. Northover J. M., Terblanche J. A new look at the arterial supply of the bile duct in man and its surgical implications. Br J Surg 1979; 66: 379-384.
12. Ohtani O., Kikuta A., Ohtsuka A., Taguchi T., Murakami T. Microvasculature as studied by the microvascular corrosion casting/scanning electron microscope method. I. Endocrine and digestive system. Arch Histol Jpn 1983; 46: 1-42.
13. Ekataksin W., Kaneda K. Liver microvascular architecture: an insight into the pathophysiology of portal hypertension. Semin Liver Dis 1999; 19: 359-382.
14. Kono N., Nakanuma Y. Ultrastructural and immunohistochemical studies of the intrahepatic peribiliary capillary plexus in normal livers and extrahepatic biliary obstruction in human beings. Hepatology 1992; 15: 411-418.
15. Matsunaga Y., Terada T. Peribiliary capillary plexus around interlobular bile ducts in various chronic liver diseases: an immunohistochemical and morphometric study. Pathol Int 1999; 49: 869-873.
16. Ludwig J., Kim C. H., Wiesner R. H., Krom R. A. Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy? Hepatology 1989; 9: 215-218.
17. Phillips M. I., Speakman E. A., Kimura B. Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul Pept 1993; 43: 1-20.
18. Bianciotti L. G., Vatta M. S., Dominguez A. E., Vescina C., Castro J. L., Magarinos J. et al. Quantitative modifications induced by angiotensin II on rat bile secretion. Regul Pept 1994; 54: 429-437.
19. Kaneda K., Ekataksin W., Sogawa M., Matsumura A., Cho A., Kawada N. Endothelin-1-induced vasoconstriction causes a significant increase in portal pressure of rat liver: localized constrictive effect on the distal segment of preterminal portal venules as revealed by light and electron microscopy and serial reconstruction. Hepatology 1998; 27: 735-747.
20. Caligiuri A., Glaser S., Rodgers R. E., Phinizy J. L., Robertson W., Papa E. et al. Endothelin-1 inhibits secretin-stimulated ductal secretion by interacting with ETA receptors on large cholangiocytes. Am J Physiol 1998; 275: G835-G846.
21. Jonsson J. R., Clouston A. D., Ando Y., Kelemen L. I., Horn M. J., Adamson M. D. et al. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 2001; 121: 148-155.